Descriptive Epidemiological Tuberculosis in Purwakarta District, 2020-2023
Abstract
Introduction: Based on the results of the Indonesian Health Survey (SKI) in 2023, prevalence of Tuberculosis based on a history of doctor diagnosis is highest in Jawa Barat Province, at 0.47%, while the national Tuberculosis prevalence is 0.30%.
Objective: This study aims to illustrate the Tuberculosis cases overview in Purwakarta District, 2020-2023.
Method: This research uses a quantitative research design with a univariate descriptive analysis approach. This study utilizes secondary data from the Tuberculosis Information System (SITB).
Result: Tuberculosis cases in Purwakarta District were highest in year 2022 (4703 cases). Based on gender, the highest cases occurred in males, with the peak in 2022 (2590 cases). The age group with the highest was the elderly age group, with the peak in 2022 (1253 cases). Tuberculosis Diabetes cases in 2022 reached 134 cases. The most accessed healthcare facility was hospitals (3317 cases) accessing healthcare services at hospitals.
Conclusion: Tuberculosis cases in Purwakarta District peaked in 2022, with the highest distribution among males and elderly. The most common comorbidity of Tuberculosis cases is diabetes, and the highest number of visits is at hospitals, indicating potential Tuberculosis issues in Purwakarta District, thus further studies regarding the Tuberculosis status in Purwakarta District are needed.
References
WHO. WHO: operational handbook on tuberculosis, Module 5: Management of tuberculosis in children and adolescents. 2022. Available at: https://apps.who.int/iris/bitstream/handle/10665/340256/9789240022 614-eng.pdf
SKI. Survei Kesehatan Indonesia (SKI) Dalam Angka Data Akurat Kebijakan Tepat. Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan RI. 2024
Najmah. Epidemiologi: Untuk Mahasiswa Kesehatan Masyarakat. PT Raja Grafindo Persada. 2015
ANDAYANI, Sri. Prediksi Kejadian Penyakit Tuberkulosis Paru Berdasarkan Jenis Kelamin. Jurnal Keperawatan Muhammadiyah Bengkulu, 2020, 8.2: 135-140.
Hermawan., Ambo., & Lymbran. Prediksi Kejadian Penyakit TB Paru BTA Positif Di Kota Kendari Tahun 2016-2020.Fakultas Kesehatan Masyarakat Universitas Halu Oleo. Vol.2, No.1, Hal. 1-10, Maret. 2015
MARLENI, Lily; SYAFEI, Abdul; SAPUTRA, Andra Dwi. Hubungan antara Pengetahuan dan Jenis Kelamin dengan Kejadian Tuberkulosis Paru. Babul Ilmi Jurnal Ilmiah Multi Science Kesehatan, 2020, 12.1.
SUNARMI, Sunarmi; KURNIAWATY, Kurniawaty. hubungan karakteristik pasien TB Paru dengan kejadian tuberkulosis. Jurnal'Aisyiyah Medika, 2022, 7.2.
HARTANTO, Teguh Dwi, et al. Analisis Spasial Persebaran Kasus Tuberkulosis Paru Di Kota Semarang Tahun 2018. Jurnal Kesehatan Masyarakat, 2019, 7.4: 719-727.
PRALAMBANG, Sesar Dayu; SETIAWAN, Sona. Faktor risiko kejadian tuberkulosis di Indonesia. Jurnal Biostatistik, Kependudukan, dan Informatika Kesehatan, 2021, 2.1: 60-71.
DAMAYANTI, Lilia. Status Pengobatan Berhubungan Dengan Kejadian Tuberkulosis Resistan Obat Pada Usia Produktif. PROFESSIONAL HEALTH JOURNAL, 2022, 3.2: 138-148.
DEWI, Ria Risti Komala; FAZRI, Ekhsan. Determinan Kejadian Tuberkulosis Paru Di Kalimantan Barat (Studi Data Riskesdas Tahun 2018). Jumantik, 2023, 9.2: 69-79.
SALAM, Salam; WAHYONO, Tri Yunis Miko. Pengaruh Jarak ke Fasilitas Pelayanan Kesehatan terhadap Kejadian Default pada Penderita TB Paru di RSUD Goeteng Taroenadibrata Purbalingga. Media Publikasi Promosi Kesehatan Indonesia (MPPKI), 2020, 3.3: 197-203.
Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:
-
Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.
-
Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.
-
License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.